Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

ClinicalTrials.gov ID: NCT00034801

Public ClinicalTrials.gov record NCT00034801. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 2:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Controlled Trial of Olanzapine Versus Active Comparator in the Treatment of Schizophrenic and Schizoaffective Subjects With Comorbid Depression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a research study comparing the safety and efficacy of two active study medications

Study identification

NCT ID
NCT00034801
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
378 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2001
Primary completion
Not listed
Completion
Feb 28, 2003
Last update posted
Jul 18, 2006

2001 – 2003

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Not listed Tuscaloosa Alabama
Not listed Little Rock Arkansas
Not listed Anaheim California
Not listed Chula Vista California
Not listed Lafayette California
Not listed Long Beach California
Not listed Orange California
Not listed Poway California
Not listed Rosemeade California
Not listed San Diego California
Not listed Denver Colorado
Not listed New Britain Connecticut
Not listed Winter Park Florida
Not listed Augusta Georgia
Not listed Prairie Village Kansas
Not listed Gaithersburg Maryland
Not listed Mount Pleasant Michigan
Not listed St Louis Missouri
Not listed Lincoln Nebraska
Not listed Clementon New Jersey
Not listed Buffalo New York
Not listed New York New York
Not listed Staten Island New York
Not listed Charlotte North Carolina
Not listed Philadelphia Pennsylvania
Not listed Sioux Falls South Dakota
Not listed Austin Texas
Not listed El Paso Texas
Not listed Houston Texas
Not listed Salt Lake City Utah

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00034801, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2006 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00034801 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →